US Patent Issued to Regeneron Pharmaceuticals on April 7 for "Human serum albumin in formulations" (New York, Connecticut Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,337, issued on April 7, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Human serum albumin in formulations" was invented by Dorothy Kim (Brooklyn, N.Y.) and Michael Marlow (Greenwich, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Drug formulations and methods for removing, reducing, or preventing the formation of fatty acid particles in drug formulations are provided. In particular, this disclosure sets forth the inclusion of human serum albumin in an active pharmaceutical agent formulation, such as an antibody drug formulation, at an effective concentration for reducing fatty acid particle formation and solubilizing fatty...